Exponent, Inc. (EXPO) Q2 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call reveals several negative factors: softer demand in chemical regulation, increased tax rate, revenue headwind due to a shorter quarter, and a decline in net income and EBITDA. The Q&A section highlighted concerns about utilization and regulatory delays. Despite some positive aspects like shareholder returns and interest income, the overall sentiment is negative due to financial underperformance and unclear guidance, leading to a predicted stock price decline of -2% to -8% over the next two weeks.
Key Financial Performance
Total Revenues Increased 1% to $142 million year-over-year. This growth was driven by demand for dispute-related services in the construction, automotive, and medical device sectors.
Net Revenues Approximately flat at $132.9 million compared to the same period in 2024. The flat performance reflects a balance between growth in certain sectors and softer demand in others.
Net Income Decreased to $26.6 million or $0.52 per diluted share, compared to $29.2 million or $0.57 per diluted share in the prior year. The decline was influenced by a higher tax rate and reduced miscellaneous income.
EBITDA Decreased 7% to $37 million, with a margin of 27.8% of net revenues compared to 30.2% in 2024. The decrease was due to lower utilization, increased operating expenses from a Phoenix land lease renewal, and loss of a tenant at the Menlo Park facility.
Billable Hours Decreased by 6% year-over-year to approximately 359,000 hours. This was partly due to the inclusion of the July 4 holiday in the second quarter, resulting in one less day of billable activity.
Technical Full-Time Equivalent Employees Decreased by 2% year-over-year to an average of 958 employees. However, the company narrowed the headcount gap from a 5%-6% deficit at the start of the year to 2% by the end of the second quarter.
Utilization Rate Decreased to 72.1% from 75.1% in the same period of 2024. The decline was partly due to the July 4 holiday affecting billable activity.
Compensation Expense Increased by 2% after adjusting for gains and losses in deferred compensation. This includes a deferred compensation gain of $17 million compared to $875,000 in 2024.
Other Operating Expenses Increased by 8% to $12.1 million, primarily due to non-cash expenses associated with the Phoenix lease extension.
G&A Expenses Increased by 2% to $6.1 million, reflecting general administrative cost growth.
Interest Income Increased to $2.3 million, driven by higher cash and cash equivalents.
Miscellaneous Income Decreased due to the loss of a tenant at the Menlo Park facility, contributing to lower overall income.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Advanced Driver Assistance Systems: Strong activity in the automotive sector related to advanced driver assistance systems.
Medical Devices: Supported high-stakes intellectual property issues alongside product liability and safety-related matters.
Artificial Intelligence Applications: Leveraging unique capabilities in scientific user research to support clients with emerging AI applications, such as evaluating human-machine interaction in safety-critical systems.
Augmented and Virtual Reality Technologies: Advising clients on safety, reliability, and quality of immersive user experiences.
Wildfire Mitigation: Expanding work in wildfire mitigation, focusing on resilient infrastructure and risk reduction strategies.
Energy Transition: Engaged in early-stage initiatives tied to distributed energy systems and large-scale battery storage.
Headcount Growth: Narrowed technical full-time equivalent employee gap from 5%-6% to 2% by the end of Q2, with expectations of further growth in Q3 and Q4.
Recruitment Efforts: Attracting top-tier talent driven by a compelling employee value proposition and development-focused culture.
Litigation-Related Activities: Continued growth in litigation-related activities fueled by rising safety and performance expectations.
Risk Management in Utility Sector: Proactive engagements evaluating resilience of critical infrastructure and mitigating safety risks.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Flat Revenue Growth: Revenues in the second quarter were flat, indicating potential challenges in achieving significant growth in a dynamic environment.
Decreased Utilization: Utilization rates dropped to 72.1% from 75.1% year-over-year, reflecting reduced efficiency in resource usage.
Headcount Challenges: Started the year with a 5%-6% deficit in technical full-time equivalent employees, narrowing to 2% by the end of Q2, but still impacting operational capacity.
Decreased Net Income: Net income decreased to $26.6 million from $29.2 million year-over-year, signaling financial pressure.
Decreased EBITDA Margins: EBITDA margins fell to 27.8% from 30.2% year-over-year, driven by lower utilization and increased operating expenses.
Increased Operating Expenses: Operating expenses rose due to factors like the Phoenix lease renewal, adding financial strain.
Loss of Rental Income: Loss of a tenant at the Menlo Park facility reduced miscellaneous income, impacting overall financial performance.
Softer Demand in Chemical Regulation: Proactive engagements in chemical regulatory work experienced softer demand, affecting revenue streams.
Tax Rate Increase: The tax rate increased to 27.9% from 26.3% year-over-year, reducing net income.
Fourth Quarter Revenue Headwind: A 13-week fourth quarter in 2025 compared to a 14-week quarter in 2024 will result in a 6% revenue headwind.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Revenue Growth: For the third quarter of 2025, revenues before reimbursements are expected to grow in the middle single digits year-over-year. For fiscal year 2025, revenues before reimbursements are projected to grow in the low single digits.
EBITDA Margin: For the third quarter of 2025, EBITDA is expected to be 26.75% to 27.75% of revenues before reimbursements. For fiscal year 2025, EBITDA is projected to be 26.5% to 27% of revenues before reimbursements.
Headcount Growth: Year-over-year technical full-time equivalent employees are expected to increase by approximately 1% to 2% for the third quarter of 2025. By year-end, headcount is projected to be approximately 4% higher than at the start of the year.
Utilization Rate: Utilization for the third quarter of 2025 is expected to be 72% to 73%, and for the full year, it is projected to be approximately 72%.
Realized Rate Increase: The realized rate increase is expected to be 4% to 5% for both the third quarter and the full year 2025.
Stock-Based Compensation: Stock-based compensation is expected to be $5.3 million to $5.5 million for the third quarter of 2025 and $23.5 million to $24 million for the full year.
Other Operating Expenses: Other operating expenses are expected to be $12.5 million to $13 million for the third quarter of 2025 and $49.5 million to $50.5 million for the full year.
G&A Expenses: G&A expenses are expected to be $7.5 million to $8 million for the third quarter of 2025 and $24.8 million to $25.5 million for the full year.
Interest Income: Interest income is expected to be $2 million to $2.2 million per quarter for the remainder of 2025.
Miscellaneous Income: Miscellaneous income is anticipated to be approximately $200,000 per quarter for the remainder of 2025.
Tax Rate: The tax rate is expected to be approximately 28% for the third quarter of 2025 and 28.5% for the full year.
Capital Expenditures: Capital expenditures for the full year 2025 are expected to be $10 million to $12 million.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Dividend Payments: Distributed $15.2 million to shareholders through dividend payments during the quarter.
Share Repurchase: Repurchased $27.7 million of common stock at an average price of $75.66 during the quarter.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:How did utilization play out in the quarter, and was the decline year-over-year solely due to the July 4 holiday?
A:Utilization came down 300 basis points, with half of the decline attributed to the July 4 holiday and the other half due to a step down from strong utilization last year (75%) and the integration of more hires this year.
Q:What were the trends throughout the quarter regarding client responses to easing tariff uncertainty and new trade deals?
A:Clients were mindful of long-term product strategies, with some softness in the chemical sector due to tariff uncertainty. There was a delay in engagements related to dossier projects and product renewals. However, the complexity of supply chains and regulatory challenges presented opportunities for the company.
Q:What are the preliminary thoughts on the revenue outlook for next year?
A:The company is in the early stages of planning for 2026. Key growth drivers include wearables and sensors, energy infrastructure, automotive advancements, and AI adoption. Quantitatively, headcount growth is expected to start at 4%, with utilization at 72% providing a foundation. Rate realization is expected to normalize to 2.5%-3.5%.
Q:How did growth rates trend in the proactive and reactive sides of the business during the quarter?
A:Growth rates were similar for both sides, within 1% of each other. Reactive work, particularly litigation and disputes, grew 7% year-over-year, offset by a decline in larger regulatory matters.
Q:Has the regulatory environment improved, remained the same, or worsened, and is it impacting demand?
A:The regulatory environment has seen delays, particularly with the EPA due to staff layoffs and turnover, causing some delays in chemical regulatory work. However, medical device-related regulatory work remains strong, with clients committed to pushing global product strategies.
Q:Review of Unclear Management Responses
A:Management avoided providing a direct answer regarding specific revenue growth expectations for 2026, using vague language and focusing on qualitative drivers rather than quantitative details.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Bank Research
Barishaw Truist
CEO Director
CFO Corporate
Conference Instructions
Conference Investor
Dr
GA
Investor Relations
Park facility
Phoenix lease
Research Division
analysis expertise
capability
cash
complexity
construction device
day
detail
device sector
engagement risk
experience
extension
headcount recruiting
income remainder
innovation
life
period decrease
quarter
reimbursement digit
resilience environment
revenue segment
science
stage
stake
strategy
system
tax share
value
wildfire
EXPO Transcript
Exponent, Inc. (EXPO) Q1 2026 Earnings Call Transcript
Unknown5-1
The earnings report shows modest revenue and income growth with improved operational efficiencies. However, the lack of discussion on strategic initiatives and operational updates, coupled with general forward-looking risks, tempers enthusiasm. The slight improvement in operating margin is positive, but the absence of guidance or new developments keeps the sentiment neutral. Given the company's market cap, the stock is unlikely to experience significant volatility.
Exponent, Inc. (EXPO) Q4 2025 Earnings Call Transcript
Positive2-5
The earnings call reflects a positive outlook with strong operational performance, increased dividends, and stock repurchases. The company is capitalizing on AI, with potential growth in consumer electronics and energy sectors. Despite some unclear management responses, the guidance indicates high single-digit growth, supported by diversification and strong demand. Although interest income decreased, cash from operations and capital allocation priorities remain strong. Given the market cap, the stock is likely to experience a moderate positive movement.
Exponent, Inc. (EXPO) Q3 2025 Earnings Call Transcript
Positive10-30
The earnings call highlights strong financial performance with increased revenues, improved utilization, and a significant realized rate increase. Shareholder returns are robust with dividends and stock repurchases. The Q&A session reveals optimism in hiring and growth, with AI integration and proactive/reactive business strategies. Despite some uncertainties in regulatory environments and rate normalization, the overall sentiment is positive, driven by strong operational metrics and strategic initiatives.
Exponent, Inc. (EXPO) Q2 2025 Earnings Call Transcript
Unknown8-1
The earnings call reveals several negative factors: softer demand in chemical regulation, increased tax rate, revenue headwind due to a shorter quarter, and a decline in net income and EBITDA. The Q&A section highlighted concerns about utilization and regulatory delays. Despite some positive aspects like shareholder returns and interest income, the overall sentiment is negative due to financial underperformance and unclear guidance, leading to a predicted stock price decline of -2% to -8% over the next two weeks.
EXPO Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
